Two Cases Detected with Pulmonary Embolism After COVID-19 Acute Period

While the coronavirus disease-2019 (COVID-19) pandemic is in full swing, its long-term effects are also noticeable over time. While the incidence of pulmonary embolism (PE) in hospitalized patients was approximately 2.6-8.9%, it was observed in one-third of patients hospitalized in the intensive care unit despite standard prophylactic anticoagulation. Although the thrombotic effects are known in the acute period and prophylactic and treatment approaches are used for this, we still need studies on how long and in whom the effects of the thrombotic process will continue. Cases of PE seen months after COVID-19 have been reported as case series in the literature. We also planned to present two patients who had PE after a diagnosis of COVID-19, one after sixteen days and the other three months later, and who had no additional risk factors, by discussing the literature.